Oxford BioDynamics PLC Sustainability Reports
Oxford BioDynamics PLC develops and commercializes precision medicine tests for life-changing diseases. Its products are built on EpiSwitch, a proprietary 3D genomic biomarker platform that enables molecular screening, evaluation, and monitoring.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
ISIN: GB00BD5H8572
10 reports from 2016 to 2025